Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Measurement of Serum Ferritin With a Cryo Detector Mass Spectrometer (CDMS)
NCT05886309
Proteomics in Multiple Trauma to Identify Organ Failure
NCT02030327
Exploring the Biological Basis of Chronic Fatigue Syndrome
NCT04859257
Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS
NCT05710770
Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
NCT04419870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Remaining portions of samples collected for diagnostic or therapeutic reasons (paired CSF and blood serum samples). No lumbar puncture will be done specifically for this protocol.
The objective of this study is to gain an overview about transition metals concentrations in blood serum and CSF in order to provide preliminary data on patients. The effect of neurodegenerative diseases on metals or the other way round will be assessed if possible.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Parkinson´s Disease
No interventions assigned to this group
Patient´s with Alzheimer´s Disease
No interventions assigned to this group
Patients with Multiple Sclerosis
No interventions assigned to this group
Patients with any other neurodegenerative diseases
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Cologne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ali Mohammad Nejad Sigaroudi
Quantification of Transition Metals in Patients at the Cologne University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Pharmacology
Cologne, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KPUK-14-Metal
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.